4.

两组患者生活质量评分

Comparison of the quality of life in the two groups

Group	n	Time	Physical well-being	Social/family well-being	Emotional well-being	Functional well-being	Other facts (lung cancer additional)	Total
Pemetrexed	23	Before therapy	18.42±3.71	14.64±2.62	13.94±3.83	12.29±3.72	23.84±3.56	92.86±8.49
		After therapy	21.17±4.49	17.26±3.97	17.02±4.13	14.58±3.96	26.49±3.48	105.41±7.53
t			2.265, 5	2.641, 6	2.622, 5	2.022, 9	2.459, 3	2.241, 5
P			< 0.05	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
Gefitinib	23	Before therapy	20.21±4.53	15.04±5.05	15.17±4.94	13.13±4.25	23.77±7.61	96.76±11.54
		After therapy	23.16±4.91	18.42±4.73	18.42±4.28	16.85±5.79	27.83±5.42	109.14±21.92
t			2.117, 8	2.342, 7	2.384, 6	2.483, 9	2.084, 1	2.396, 8
P			< 0.05	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
Pemetrexed	23	D-value before therapy	5.52±3.83	5.37±3.74	4.56±3.97	5.24±3.51	5.05±5.84	19.44±2.27
Gefitinib	23	D-value after therapy	6.93±2.56	6.99±4.72	6.94±3.85	7.58±4.26	8.67±6.03	31.47±2.61
t			1.467, 9	1.290, 1	2.064, 0	2.033, 2	2.068, 1
P			> 0.05	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05